Cargando…

Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer

PURPOSE: Breast cancer patients with high proportion of cancer stem cells (BCSCs) have unfavorable clinical outcomes. MicroRNAs (miRNAs) regulate key features of BCSCs. We hypothesized that a biology-driven model based on BCSC-associated miRNAs could predict prognosis for the most common subtype, ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Chang, Tan, Weige, Chen, Kai, You, Na, Zhu, Shan, Liang, Gehao, Xie, Xinhua, Li, Qian, Zeng, Yunjie, Ouyang, Nengtai, Li, Zhihua, Zeng, Musheng, Zhuang, ShiMei, Lau, Wan-Yee, Liu, Qiang, Yin, Dong, Wang, Xueqin, Su, Fengxi, Song, Erwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049991/ https://www.ncbi.nlm.nih.gov/pubmed/27566954 http://dx.doi.org/10.1016/j.ebiom.2016.08.016

Ejemplares similares

A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer
por: Tan, Weige, et al.
Publicado: (2016)

Association of BCSC-1 and MMP-14 with human breast cancer
por: Di, Dalin, et al.
Publicado: (2018)

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
por: Li, Huiping, et al.
Publicado: (2018)

Nerve Fibers in Breast Cancer Tissues Indicate Aggressive Tumor Progression
por: Huang, Di, et al.
Publicado: (2014)

Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis
por: Tan, Weige, et al.
Publicado: (2016)

BR-BCSC Signature: The Cancer Stem Cell Profile Enriched in Brain Metastases that Predicts a Worse Prognosis in Lymph Node-Positive Breast Cancer
por: Dionísio, Maria Rita, et al.
Publicado: (2020)

HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy
por: Jia, Haixia, et al.
Publicado: (2014)

Blocking the recruitment of naive CD4(+) T cells reverses immunosuppression in breast cancer
por: Su, Shicheng, et al.
Publicado: (2017)

MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth
por: Li, Miao, et al.
Publicado: (2020)

Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p
por: Liu, Zihao, et al.
Publicado: (2019)

circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer
por: Ling, Yun, et al.
Publicado: (2022)

Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer
por: Tan, Weige, et al.
Publicado: (2019)

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study
por: Gu, Ran, et al.
Publicado: (2012)

Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression
por: Liang, Gehao, et al.
Publicado: (2020)

Multigene Expression Signatures in Early Hormone Receptor Positive HER 2 Negative Breast Cancer
por: Ovcaricek, Tanja, et al.
Publicado: (2019)

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program
por: Su, Shicheng, et al.
Publicado: (2015)

Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
por: Zeng, Erwei, et al.
Publicado: (2022)

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
por: Liu, Jieqiong, et al.
Publicado: (2020)

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
por: Ding, Yi, et al.
Publicado: (2018)

Concomitant Discontinuation of Cardiovascular Therapy and Adjuvant Hormone Therapy Among Patients With Breast Cancer
por: He, Wei, et al.
Publicado: (2023)

ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma
por: Hu, Qian, et al.
Publicado: (2018)

A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats
por: OUYANG, NENGTAI, et al.
Publicado: (2012)

MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-β pathway in NSCLC
por: Fang, Lishan, et al.
Publicado: (2018)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

Breast-conserving Surgery Rates in Breast Cancer Patients With Different Molecular Subtypes: An Observational Study Based on Surveillance, Epidemiology, and End Results (SEER) Database
por: Chen, Kai, et al.
Publicado: (2016)

MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYL
por: Liang, Gehao, et al.
Publicado: (2021)

Long noncoding RNA LINC00673-v4 promotes aggressiveness of lung adenocarcinoma via activating WNT/β-catenin signaling
por: Guan, Hongyu, et al.
Publicado: (2019)

EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression
por: Liu, Lei, et al.
Publicado: (2018)

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patients
por: Liu, Binliang, et al.
Publicado: (2022)

Hormone gene signature guides a novel therapeutic opportunity to improve sensitivity to HER family inhibition in lung cancer
por: Yochum, Zachary A., et al.
Publicado: (2020)

Effects of Strain and Electric Field on Molecular Doping in MoSSe
por: Zeng, Jincheng, et al.
Publicado: (2021)

Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis
por: Chen, Kai, et al.
Publicado: (2015)

In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery
por: Zhu, Liling, et al.
Publicado: (2019)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC
por: Tang, Yu, et al.
Publicado: (2022)

Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer
por: Zheng, Yuanyuan, et al.
Publicado: (2022)

Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer
por: Gong, Chang, et al.
Publicado: (2010)

Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas
por: Huang, Yongsheng, et al.
Publicado: (2022)

Gut Microbiota Signatures in Gestational Anemia
por: Long, Yan, et al.
Publicado: (2021)

Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer
por: Maddox, Adam L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_in7uj7pj0l1vn6qcpkc43520bs